Bulletin
Investor Alert

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

After Hours

 --Real time quotes

Nov 29, 2023, 7:59 p.m.

/zigman2/quotes/207657083/composite

$

0.32

Change

+0.0061 +1.93%

Volume

Volume 13,883

Real time quotes

/zigman2/quotes/207657083/composite

Today's close

$ 0.34

$ 0.32

Change

-0.02 -6.02%

Day low

Day high

$0.31

$0.34

Open

52 week low

52 week high

$0.22

$2.51

Open

Joshua F. Patterson

Joshua F. Patterson occupies the position of Chief Compliance Officer & General Counsel at Gamida Cell Ltd.

He previously held the position of Executive Director & Deputy General Counsel at Ionis Pharmaceuticals, Inc. and General Counsel for Akcea Therapeutics, Inc. (a subsidiary of Ionis Pharmaceuticals, Inc.) and In-House Counsel at Amylin Pharmaceuticals, Inc.

He received an undergraduate degree from Carthage College and a graduate degree from Syracuse University.

Transactions

Date Shares Transaction Value
02/08/2023 63,000   Award at $0 per share. 0
01/28/2022 51,000   Award at $0 per share. 0

Officers and Executives

Ms. Abigail L. Jenkins
President, Chief Executive Officer & Director
Ms. Michele I. Korfin
Chief Operating & Commercial Officer
Ms. Mary Theresa Coelho
Chief Financial & Accounting Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Director-Investor Relations & Communications
Ms. Shawn Cline Tomasello
Chairman
Mr. Stephen T. Wills
Independent Director
Dr. Ivan M. Borrello
Independent Director
Dr. Julian Adams
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.